AC Immune (ACIU) Receivables - Other (2014 - 2026)

AC Immune (ACIU) has 13 years of Receivables - Other data on file, last reported at $1.6 billion in Q1 2026.

• On a quarterly basis, Receivables - Other rose 73939.16% year-over-year to $1.6 billion in Q1 2026; TTM through Mar 2026 was $1.6 billion, a 73939.16% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 93500.71% from the prior year.
• Receivables - Other for Q1 2026 stood at $1.6 billion, up from $1.2 billion in the prior quarter.
• Over the last five years, Receivables - Other for ACIU reached as high as $1.6 billion in Q1 2026 and fell as low as $336989.2 in Q2 2023.
• Historically, Receivables - Other has averaged $206.7 million across 5 years, with a median of $1.3 million in 2024.
• Across the five-year window, Receivables - Other sank 99.91% in 2022 and surged 96996.1% in 2025, its largest moves.
• Year by year, Receivables - Other stood at $406904.6 in 2022, then surged by 72.33% to $701214.5 in 2023, then jumped by 79.72% to $1.3 million in 2024, then jumped by 96996.1% to $1.2 billion in 2025, then soared by 33.79% to $1.6 billion in 2026.
• Per Business Quant data, the three most recent Receivables - Other figures were $1.6 billion in Q1 2026, $1.2 billion in Q4 2025, and $2.0 million in Q3 2025.